Suppr超能文献

关于改进小鼠TNBS诱导的结肠炎模型在评估乳酸菌抗炎特性中应用的建议:技术和微生物学方面

Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects.

作者信息

Foligné Benoit, Nutten Sophie, Steidler Lothar, Dennin Véronique, Goudercourt Denise, Mercenier Annick, Pot Bruno

机构信息

Bactériologie des Ecosystémes, Institut Pasteur de Lille, Lille, France.

出版信息

Dig Dis Sci. 2006 Feb;51(2):390-400. doi: 10.1007/s10620-006-3143-x.

Abstract

Probiotic bacteria have been shown to exert promising beneficial effects in different types of intestinal disorders, including chronic inflammation. In this context, animal models of inflammatory bowel disease are useful in studying the possible prophylactic role of candidate probiotic strains. This study aimed at evaluating the critical technological and microbiological parameters as well as the robustness of the murine trinitrobenzene sulfonic acid (TNBS)-induced model of colitis, after intragastric administration of lactic acid bacteria (LAB) preparations. A standardized methodology was applied to assess the protective effect achieved by various bacterial concentrations and culture conditions of the reference strain Lactobacillus plantarum NCIMB 8826. Not only was protection found to vary in function in different levels of colitis, but also repeated experiments showed a clear bacterial dose-dependent attenuation of colitis. The physiological stage of bacteria was shown to impact as well, with substantial, mild, or reduced improvement of inflammatory scores for exponentially growing, stationary-phase, or killed bacteria, respectively. A recombinant strain, secreting murine interleukin-10 (IL-10) and previously reported to successfully treat colitis in two different models of murine colitis (dextran sulfate sodium [DSS] and IL-10-deficient mice), was used to validate the final experimental conditions. In conclusion, we identified and optimized some of the key parameters that need to be controlled in order to ensure reliable comparison of results generated over a long period of time or independent experiments. The recommendations for an improved model presented here will prove to be helpful for reproducible, independent comparison of the anti-inflammatory potential of wild-type or recombinant candidate probiotic strains, whether administered as pure cultures or as blends.

摘要

益生菌已被证明在包括慢性炎症在内的不同类型肠道疾病中发挥着有益作用。在此背景下,炎症性肠病动物模型有助于研究候选益生菌菌株可能的预防作用。本研究旨在评估小鼠三硝基苯磺酸(TNBS)诱导的结肠炎模型在胃内给予乳酸菌(LAB)制剂后的关键技术和微生物学参数以及稳健性。应用标准化方法评估参考菌株植物乳杆菌NCIMB 8826在不同细菌浓度和培养条件下所实现的保护作用。结果发现,保护作用不仅在不同程度的结肠炎中有所不同,而且重复实验表明结肠炎的减轻呈明显的细菌剂量依赖性。细菌的生理阶段也有影响,对数生长期、稳定期或灭活细菌的炎症评分改善程度分别为显著、轻微或降低。一种分泌小鼠白细胞介素-10(IL-10)且先前报道在两种不同的小鼠结肠炎模型(葡聚糖硫酸钠[DSS]和IL-10缺陷小鼠)中成功治疗结肠炎的重组菌株,被用于验证最终实验条件。总之,我们确定并优化了一些关键参数,这些参数需要加以控制,以确保长期或独立实验结果的可靠比较。本文提出的改进模型建议将有助于对野生型或重组候选益生菌菌株的抗炎潜力进行可重复、独立的比较,无论这些菌株是以纯培养物还是混合形式给药。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验